About Conceivable Life Sciences
Conceivable Life Sciences is a private company based in New York, New York, incorporated in 2022 in Delaware. It has reported $63,472,159 raised in three offerings on Form D since July 2023.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 5, 2025 | Sep 15, 2025 | $30,499,997of $33.0M target | 20 | $1.5M | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Nov 22, 2024 | Dec 17, 2024amended Jan 2, 2025 | $15,997,162of $18.0M target | 18 | $888K | Debt, Convertible promissory notesRule 506(b) | Form D/A ↗1 earlier filing |
| Jul 7, 2023 | Jul 20, 2023 | $16,975,000of $20.0M target | 11 | $1.5M | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, three offerings | $63,472,159 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Conceivable Life Sciences's Form D filed Sep 15, 2025.
AC
Alex Christ
Director
AB
Alejandro Chavez-Badiola
Executive officer and director
SP
Stuart Peterson
Director
AH
Aike Ho
Director
FD
Fred Destin
Director
Earlier filings also listed Joshua Abram (executive officer and director, last listed Jan 2025).